BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
Drug design, drug delivery and technologies RSS Feed RSS

Electroporation shown to be effective for local delivery of agents for restenosis

April 3, 1997

Sheffield licenses Siemens multidose inhaler

April 3, 1997

Preliminary data reported from Alkermes' RMP-7/carboplatin phase II trial

April 2, 1997

Inhale granted U.S. patent for pulmonary delivery of osteoporosis drug

March 25, 1997

Aprogenex and Centocor sign licensing agreement

March 24, 1997

Xenova and Zeneca enter drug discovery collaboration

March 21, 1997

Oncogene Science and Sepracor enter drug discovery collaboration

March 20, 1997

Oncogene Science granted rights to Dow's compound library

March 20, 1997

Enzo receives notice of allowance of Japanese patent for antisense technology

March 20, 1997

Lilly and Kyowa Hakko enter combinatorial chemistry collaboration

March 19, 1997
Previous 1 2 … 380 381 382 383 384 385 386 387 388 … 414 415 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Cerebral aneurysm illustration

    Grace Therapeutics hits CRL setback with GTx-104 despite positive trial

    BioWorld
    Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
  • Epileptic brain and abnormal EEG wave discharges

    Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest

    BioWorld
    A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
  • Gold-encircled handshake

    Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal

    BioWorld
    The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing